Maria-Gabriela Velez ,Vivek Bhalla *
Diabetic nephropathy (DN) is the most common cause of end-stage renal disease (ESRD) in adults. Despite our current understanding of the disease, we cannot accurately predict which patients with diabetes will develop nephropathy, and we cannot halt the progression to ESRD. Research on the role of the immune system in DN may shed light on novel biomarkers and therapies for this severe complication of diabetes mellitus. In this review we examine the current knowledge of the role of immune system in the development and progression of diabetic nephropathy, speculate on the potential role of B lymphocytes, and highlight implications for prognosis and therapy.
分享此文章
English 
Spanish 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi 